Mark W. Begor - Jul 28, 2025 Form 4 Insider Report for EQUIFAX INC (EFX)

Role
CEO, Director
Signature
/s/Lisa Stockard as Attorney-in-Fact
Stock symbol
EFX
Transactions as of
Jul 28, 2025
Transactions value $
-$6,313,351
Form type
4
Date filed
7/30/2025, 04:20 PM
Previous filing
May 23, 2025
Next filing
Oct 29, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Begor Mark W CEO, Director 1550 PEACHTREE STREET, N.W., ATLANTA /s/Lisa Stockard as Attorney-in-Fact 2025-07-30 0001335111

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFX Common Stock Options Exercise $5.35M +28K +17.13% $191.44 191K Jul 28, 2025 Direct
transaction EFX Common Stock Sale -$89.2K -364 -0.19% $244.95 191K Jul 28, 2025 Direct F1, F2, F3
transaction EFX Common Stock Sale -$203K -831 -0.44% $243.90 190K Jul 28, 2025 Direct F1, F3, F4
transaction EFX Common Stock Sale -$2.3M -9.5K -5% $242.70 180K Jul 28, 2025 Direct F1, F3, F5
transaction EFX Common Stock Sale -$4.29M -17.7K -9.83% $241.87 163K Jul 28, 2025 Direct F1, F3, F6
transaction EFX Common Stock Sale -$4.78M -19.8K -12.19% $240.95 143K Jul 28, 2025 Direct F1, F3, F7
holding EFX Common Stock 10.5K Jul 28, 2025 2-yr 2025 GRAT
holding EFX Common Stock 9.53K Jul 28, 2025 2-yr Feb 2024 GRAT
holding EFX Common Stock 11.4K Jul 28, 2025 2-yr Jul 2024 GRAT
holding EFX Common Stock 43.4K Jul 28, 2025 2-yr Jun 2025 GRAT
holding EFX Common Stock 12.3K Jul 28, 2025 2-yr May 2025 GRAT
holding EFX Common Stock 16.3K Jul 28, 2025 3-yr Jul 2024 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFX Stock Option/Right to Buy Options Exercise $0 -28K -50% $0.00 28K Jul 28, 2025 Common Stock 28K $191.44 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2024.
F2 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $244.72 to $245.33, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F3 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $243.47 to $244.44, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $242.41 to $243.17, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F6 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $241.41 to $242.40, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F7 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $240.40 to $241.39, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F8 The option vested in three equal annual increments beginning 2/21/2021.